Search - tctmd.com

Displaying 541 - 560 of 1139

Sort: Relevancy | Date

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Doctors Rely on Clinic BP, Automated Tools at Patient’s Peril

Michael O'Riordan

September 11, 2020

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

Advertisement

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Just One-Third of European Patients Get to LDL Cholesterol Goals

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Hostility After ACS Linked to All-Cause Mortality

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Doctors Rely on Clinic BP, Automated Tools at Patient’s Peril

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content